According to Eagle Pharmaceuticals
's latest financial reports the company's current revenue (TTM ) is ยฃ0.19 Billion. In 2022 the company made a revenue of ยฃ0.26 Billion an increase over the revenue in the year 2021 that were of ยฃ0.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | ยฃ0.21 B | -18.25% |
2022 | ยฃ0.26 B | 105.93% |
2021 | ยฃ0.12 B | -7.76% |
2020 | ยฃ0.13 B | -7.77% |
2019 | ยฃ0.14 B | -11.1% |
2018 | ยฃ0.16 B | -4.05% |
2017 | ยฃ0.17 B | 14.05% |
2016 | ยฃ0.15 B | 243.61% |
2015 | ยฃ44.69 M | 262.25% |
2014 | ยฃ12.33 M | 15.05% |
2013 | ยฃ10.72 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | ยฃ66.89 B | 34,584.78% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | ยฃ30.39 B | 15,658.66% | ๐ฌ๐ง UK |
![]() Novartis NVS | ยฃ39.85 B | 20,564.65% | ๐จ๐ญ Switzerland |
![]() Teva Pharmaceutical Industries TEVA | ยฃ12.44 B | 6,351.15% | ๐ฎ๐ฑ Israel |
![]() Amgen AMGN | ยฃ25.55 B | 13,150.19% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | ยฃ36.69 B | 18,926.60% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | ยฃ35.67 B | 18,395.75% | ๐บ๐ธ USA |